External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

SLEuro 2024

-
Coming soon
11:20 AM
Duration 10mins Concert Hall
Longitudinal assessment of biomarkers in NOBILITY, a randomized, phase II clinical trial of obinutuzumab for treatment of proliferative lupus nephritis
Richard Furie

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
07:45 AM
Duration 2mins Bruges, Belgium
Welcome and introduction presentation 1
Professor Liz Lightstone
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
07:47 AM
Duration 10mins Bruges, Belgium
Management of lupus nephritis: current perspectives and future directions presentation 2
Associate Professor Ioannis Parodis
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
07:57 AM
Duration 12mins Bruges, Belgium
Practical management of lupus nephritis: a case presentation
Professor Liz Lightstone & Assoc Proffessor Ioannis Parodis
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
08:09 AM
Duration 6mins Bruges, Belgium
Q&A
Professor Liz Lightstone & Assoc Proffessor Ioannis Parodis
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar